Shelter Pharma Ltd has announced its participation in the 12th Edition of iPHEX 2026, one of India's leading international pharmaceutical and healthcare exhibitions. The event is scheduled to take place from September 7, 2026, to September 9, 2026, at Bharat Mandapam. The exhibition is organized by the Pharmaceuticals Export Promotion Council of India with the support of the Department of Commerce, Government of India.

The company has secured an exhibition stall to showcase its pharmaceutical and healthcare product portfolio. The target audience includes domestic and international business delegates, distributors, importers, and other industry participants. This strategic move is intended to enhance the company's global visibility and brand recognition.

Strategic Objectives

Participation in iPHEX 2026 is expected to yield several strategic benefits for the company:

• Strengthen relationships with existing customers and business associates
• Explore new export opportunities and international market expansion
• Facilitate B2B interactions with overseas buyers and healthcare stakeholders

The management believes that engaging in such globally recognized industry exhibitions aligns with Shelter Pharma's long-term growth and business development strategy.

Event Details

Shelter Pharma Limited has received a work order from Verka Dairies for the supply of veterinary medicines under a rate contract for a period of one year. The development follows the company's earlier successful qualification in both the technical and negotiation/financial rounds of the tender process, as intimated on 6th April, 2026. The order was formally communicated to BSE Limited on 15th May, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

About the Client

Verka Dairies is a flagship dairy brand of MILKFED Punjab and is recognised as one of the leading and most trusted dairy brands in North India. The organisation enjoys a strong market presence and consumer trust across multiple states. The receipt of this work order from such a reputed entity reflects the confidence placed by the client in Shelter Pharma's capabilities and quality standards.

Key Order Details

The following table outlines the significant terms and conditions associated with the work order, as disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015:

Compliance and Corporate Disclosures

The company has confirmed that neither the promoter nor the promoter group or group companies have any interest in Verka Dairies, the entity that awarded the order. Additionally, the transaction does not fall within the scope of related party transactions under applicable regulations. The disclosure was signed by Mustaqim Nisarahmed Sabugar, Managing Director of Shelter Pharma Limited, from Ahmedabad on 15th May, 2026.

Significance of the Order

The successful award of this tender underscores Shelter Pharma's commitment to maintaining high-quality products, timely execution, and reliable services. The order is expected to contribute positively to the company's revenues, profitability, and overall business growth. Management has indicated that such achievements are anticipated to further strengthen the company's market presence and order book, while creating long-term value for stakeholders.